LGALS3BP, galectin 3 binding protein, 3959

N. diseases: 127; N. variants: 0
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0019163
Disease: Hepatitis B
Hepatitis B
0.050 AlteredExpression disease BEFREE The WFA<sup>+</sup> -M2BP levels were measured in stored samples collected at initial diagnosis of 150 patients with HBV-related HCC and 150 age- and gender-matched patients with non-malignant chronic HBV infection. 29732647 2018
CUI: C0019163
Disease: Hepatitis B
Hepatitis B
0.050 AlteredExpression disease BEFREE WFA<sup>+</sup> -M2BP levels increased with elevated Child-Pugh classification, especially in patients with hepatitis B virus (HBV) infection. 29607614 2018
CUI: C0019163
Disease: Hepatitis B
Hepatitis B
0.050 AlteredExpression disease BEFREE Changes in WFA<sup>+</sup> -M2BP levels were parallel with those in FibroScan values during nucleot(s)ide analogues therapy in patients with chronic HBV infection. 27300763 2017
CUI: C0019163
Disease: Hepatitis B
Hepatitis B
0.050 Biomarker disease BEFREE Serum WFA<sup>+</sup> -M2BP values appear to be useful for assessing liver fibrosis stage and are independently associated with HCC development in patients with chronic HBV infection. 27029022 2017
CUI: C0019163
Disease: Hepatitis B
Hepatitis B
0.050 Biomarker disease BEFREE Serum microRNA-122 and Wisteria floribunda agglutinin-positive Mac-2 binding protein are useful tools for liquid biopsy of the patients with hepatitis B virus and advanced liver fibrosis. 28475652 2017